Profil
Clayton Robertson worked as an Analyst at Trout Capital LLC.
Served as Investor Relations Contact at Achillion Pharmaceuticals, Inc. from 2019 to 2020.
Worked as Director-Investor Relations at PureTech Health Plc in 2020.
Worked as Director-Investor Relations at Actinium Pharmaceuticals, Inc. from 2020 to 2021.
Worked as Head-Investor Relations at Immunocore Holdings Plc from 2021 to 2026.
Completed undergraduate education at the University of Pennsylvania.
Ehemalige bekannte Positionen von Clayton Robertson
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Investor Relations Kontakt | 01.02.2026 |
| ACTINIUM PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.02.2021 |
| PURETECH HEALTH PLC | Investor Relations Kontakt | 01.08.2020 |
| ACHILLION PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.05.2020 |
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Ausbildung von Clayton Robertson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
















